Literature DB >> 21524954

Epidemiologic and clinical features of non-polio enteroviral infections in northern Taiwan in 2008.

Chien-Hui Hsu1, Chun-Yi Lu, Pei-Lan Shao, Ping-Ing Lee, Chuan-Liang Kao, Ming-Yi Chung, Luan-Yin Chang, Li-Min Huang.   

Abstract

BACKGROUND: Non-polio enteroviruses may cause different diseases, including herpangina, hand-foot-mouth disease (HFMD), meningitis, and nonspecific febrile illness; and cause epidemic outbreak annually. This study delineates the diversity of clinical presentations based on different serotypes and different groups [human enterovirus (HEV)-A and HEV-B] of enteroviruses (EVs) during the 2008 epidemic in National Taiwan University Hospital (NTUH).
METHODS: We retrospectively identified patients younger than 18 years who had positive isolates of non-polio EV in throat swabs, rectal swabs, or cerebrospinal fluid, in NTUH from January 1 to December 31, 2008. For serotyping, immunofluorescence assay and polymerase chain reaction followed by viral structure protein-1 sequencing were applied. We analyzed and compared their clinical features among different serotypes and different groups of EVs.
RESULTS: Among 172 patients who were enrolled, 16 serotypes were identified. The major serotype in NTUH was EV71 (25.6%) followed by coxsackievirus A (CA)16 and coxsackievirus B (CB)4. EV71 manifested mostly as HFMD (89%) and was complicated with encephalomyelitis in three patients. Serotypes of HFMD included EV71 (70%), CA16 (27%), CA4, and CA6. Serotypes of herpangina were heterogeneous, and the major serotype was CA2 (35.7%) followed by CB4 (23.8%). Aseptic meningitis was entirely caused by HEV-B and mostly infected by echovirus 30 (50%). Among children with EV-related respiratory tract infection, CB4 (32%) was dominant in upper respiratory tract infection, whereas echovirus 4 (71%) was the major cause of lower respiratory tract infection. Cases of HEV-A were significantly younger than the cases of HEV-B (p = 0.04). Multivariate analysis revealed that the most significant factor associated with hospitalization is HEV-B (odds ratio, 2.2; 95% confidence interval, 1.1-4.2; p = 0.02).
CONCLUSIONS: At least 16 serotypes circulated in northern Taiwan in 2008. EV71 is the predominant strain in this outbreak. All patients with HFMD were infected by HEV-A, but HEV-B was associated with a higher rate of hospitalization and aseptic meningitis, which should be a cause of alert regarding public health.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2011        PMID: 21524954     DOI: 10.1016/j.jmii.2011.01.029

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  22 in total

Review 1.  Is a multivalent hand, foot, and mouth disease vaccine feasible?

Authors:  Michel Klein; Pele Chong
Journal:  Hum Vaccin Immunother       Date:  2015-05-26       Impact factor: 3.452

2.  Epidemics and aetiology of hand, foot and mouth disease in Xiamen, China, from 2008 to 2015.

Authors:  S Z He; M Y Chen; X R Xu; Q Yan; J J Niu; W H Wu; X S Su; S X Ge; S Y Zhang; N S Xia
Journal:  Epidemiol Infect       Date:  2017-04-03       Impact factor: 4.434

3.  Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants.

Authors:  Feng-Cai Zhu; Zheng-Lun Liang; Fan-Yue Meng; Ying Zeng; Qun-Ying Mao; Kai Chu; Xue-Fang Song; Xin Yao; Jing-Xin Li; Hong Ji; Yi-Ju Zhang; Liang Li; Hong-Xing Pan; Ke Xu; Wei-Ming Dai; Wei-Wei Zhang; Fei Deng; Hua Wang; Jun-Zhi Wang
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

4.  Clinical features of coxsackievirus A4, B3 and B4 infections in children.

Authors:  Chia-Jie Lee; Yhu-Chering Huang; Shuan Yang; Kuo-Chien Tsao; Chih-Jung Chen; Yu-Chia Hsieh; Cheng-Hsun Chiu; Tzou-Yien Lin
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

5.  Epidemics and Frequent Recombination within Species in Outbreaks of Human Enterovirus B-Associated Hand, Foot and Mouth Disease in Shandong China in 2010 and 2011.

Authors:  Ting Zhang; Jiang Du; Ying Xue; Haoxiang Su; Fan Yang; Qi Jin
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

6.  Development and evaluation of a pseudovirus-luciferase assay for rapid and quantitative detection of neutralizing antibodies against enterovirus 71.

Authors:  Xing Wu; Qunying Mao; Xin Yao; Pan Chen; Xiangmei Chen; Jie Shao; Fan Gao; Xiang Yu; Fengcai Zhu; Rongcheng Li; Wenhui Li; Zhenglun Liang; Junzhi Wang; Fengmin Lu
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

7.  Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province, China.

Authors:  Hong Ji; Liang Li; YanMing Liu; HengMing Ge; XuShan Wang; Jianli Hu; Bin Wu; JianGuang Fu; ZhenYu Zhang; XiaoQin Chen; MingLei Zhang; Qiang Ding; WenBo Xu; FenYang Tang; MingHao Zhou; Hua Wang; FengCai Zhu
Journal:  Virol J       Date:  2012-10-29       Impact factor: 4.099

8.  Clinical features and phylogenetic analysis of Coxsackievirus A9 in Northern Taiwan in 2011.

Authors:  Yi-Chuan Huang; Ying-Hsia Chu; Ting-Yu Yen; Wen-Chan Huang; Li-Min Huang; Ai-Ling Cheng; Hurng-Yi Wang; Luan-Yin Chang
Journal:  BMC Infect Dis       Date:  2013-01-24       Impact factor: 3.090

9.  Chlorogenic acid inhibits the replication and viability of enterovirus 71 in vitro.

Authors:  Xiang Li; Yuanyuan Liu; Xueling Hou; Hongjun Peng; Li Zhang; Qingbo Jiang; Mei Shi; Yun Ji; Yuyue Wang; Weifeng Shi
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

10.  The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children.

Authors:  Qunying Mao; Tong Cheng; Fengcai Zhu; Jingxin Li; Yiping Wang; Yanping Li; Fan Gao; Lisheng Yang; Xin Yao; Jie Shao; Ningshao Xia; Zhenglun Liang; Junzhi Wang
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.